# Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population

> **NCT05778851** · NA · COMPLETED · sponsor: **Lucid Diagnostics, Inc.** · enrollment: 97 (actual)

## Conditions studied

- Barrett Esophagus

## Interventions

- **DEVICE:** EsoGuard result

## Key facts

- **NCT ID:** NCT05778851
- **Lead sponsor:** Lucid Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-12
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-08-19
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05778851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05778851, "Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT05778851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*